These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

60 related items for PubMed ID: 1914846

  • 1. Rheological activity of propionyl L-carnitine.
    Pola P, Flore R, Tondi P, Nolfe G.
    Drugs Exp Clin Res; 1991; 17(3):191-6. PubMed ID: 1914846
    [Abstract] [Full Text] [Related]

  • 2. Effects of propionyl-L-carnitine on peripheral arterial obliterative disease of the lower limbs: a double-blind clinical trial.
    Dal Lago A, De Martini D, Flore R, Gaetani E, Gasbarrini A, Gerardino L, Pola R, Santoliquido A, Serricchio M, Tondi P, Nolfe G.
    Drugs Exp Clin Res; 1999; 25(1):29-36. PubMed ID: 10337502
    [Abstract] [Full Text] [Related]

  • 3. Effect of L-propionyl carnitine on some properties of erythrocytes and leukocytes of alcohol abusers.
    Conte A, Bianchi I, Guazzelli M, Taponeco G, Bertelli A, Ronca G.
    Int J Tissue React; 1995; 17(1):21-31. PubMed ID: 7499061
    [Abstract] [Full Text] [Related]

  • 4. Reversal of cisplatin-induced carnitine deficiency and energy starvation by propionyl-L-carnitine in rat kidney tissues.
    Aleisa AM, Al-Majed AA, Al-Yahya AA, Al-Rejaie SS, Bakheet SA, Al-Shabanah OA, Sayed-Ahmed MM.
    Clin Exp Pharmacol Physiol; 2007 Dec; 34(12):1252-9. PubMed ID: 17973863
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of the efficacy of propionyl-L-carnitine versus pulsed muscular compressions in diabetic and non-diabetic patients affected by obliterating arteriopathy Leriche stage II.
    Riccioni C, Sarcinella R, Palermo G, Izzo A, Liguori M, Koverech A, Messano M, Virmani A.
    Int Angiol; 2008 Jun; 27(3):253-9. PubMed ID: 18506129
    [Abstract] [Full Text] [Related]

  • 6. The action of propionyl-L-carnitine on the vasal endothelium: increased t-PA synthesis and a decrease in the activity of PAI-1. A preliminary study.
    Pola P, De Martini D, Gerardino L, De Rossi S, Tondi P.
    Drugs Exp Clin Res; 1992 Jun; 18(8):343-8. PubMed ID: 1292917
    [Abstract] [Full Text] [Related]

  • 7. New carnitine derivatives for the therapy of cutaneous ulcers in vasculopathics.
    Pola P, Flore R, Serricchio M, Tondi P.
    Drugs Exp Clin Res; 1991 Jun; 17(5):277-82. PubMed ID: 1756691
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review.
    Ferrari R, Merli E, Cicchitelli G, Mele D, Fucili A, Ceconi C.
    Ann N Y Acad Sci; 2004 Nov; 1033():79-91. PubMed ID: 15591005
    [Abstract] [Full Text] [Related]

  • 9. Effect of L-propionyl carnitine on in-vitro membrane alteration of sickle-cell anaemia erythrocytes.
    Ronca F, Palmieri L, Malengo S, Bertelli A.
    Int J Tissue React; 1994 Nov; 16(4):187-94. PubMed ID: 7797405
    [Abstract] [Full Text] [Related]

  • 10. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study.
    Brevetti G, Perna S, Sabbá C, Martone VD, Condorelli M.
    J Am Coll Cardiol; 1995 Nov 15; 26(6):1411-6. PubMed ID: 7594063
    [Abstract] [Full Text] [Related]

  • 11. Uptake of [N-methyl-11C]propionyl-L-carnitine (PLC) in human myocardium.
    Cunningham VJ, Rosen SD, Boyd H, Osman S, Davenport RJ, Gunn RN, Pike VW, Camici PG.
    J Pharmacol Exp Ther; 1996 Apr 15; 277(1):511-7. PubMed ID: 8613961
    [Abstract] [Full Text] [Related]

  • 12. Effects of propionyl-L-carnitine topical irrigation in distal ulcerative colitis: a preliminary report.
    Gasbarrini G, Mingrone G, Giancaterini A, De Gaetano A, Scarfone A, Capristo E, Calvani M, Caso V, Greco AV.
    Hepatogastroenterology; 2003 Apr 15; 50(53):1385-9. PubMed ID: 14571743
    [Abstract] [Full Text] [Related]

  • 13. Effect of buflomedil, dipyridamole and indobufene on hemorrheologic and blood coagulation parameters in patients who underwent vascular surgery for severe atherosclerosis.
    Mares M, Sogaro F, Scomparin MA, Boeri G, Cella G.
    J Med; 1991 Apr 15; 22(3):163-9. PubMed ID: 1770324
    [Abstract] [Full Text] [Related]

  • 14. Effect of propionyl-L-carnitine, L-arginine and nicotinic acid on the efficacy of vardenafil in the treatment of erectile dysfunction in diabetes.
    Gentile V, Antonini G, Antonella Bertozzi M, Dinelli N, Rizzo C, Ashraf Virmani M, Koverech A.
    Curr Med Res Opin; 2009 Sep 15; 25(9):2223-8. PubMed ID: 19624286
    [Abstract] [Full Text] [Related]

  • 15. L-propionyl carnitine reduces toxicity correlated to cyclosporine-induced intracellular ATP concentrations.
    Giovannini L, Migliori M, De Pietro S, Taccola D, Panichi V, Bertelli AA, Bertelli A.
    Drugs Exp Clin Res; 1999 Sep 15; 25(4):173-7. PubMed ID: 10442274
    [Abstract] [Full Text] [Related]

  • 16. [Flowmetric, thermometric and rheologic studies in obliterating arterial diseases of the lower extremities treated with buflomedil].
    Dorigo B, Raspanti D, Trapani M, Albanese B, Cameli AM, Digiesi V.
    Minerva Med; 1985 Feb 25; 76(7):269-75. PubMed ID: 3974940
    [Abstract] [Full Text] [Related]

  • 17. Short term effects of intra-arterial propionyl-L-carnitine on isolated canine hind-limbs.
    Cevese A, Schena F, Poltronieri R, Cerutti G.
    Cardioscience; 1995 Mar 25; 6(1):59-64. PubMed ID: 7605897
    [Abstract] [Full Text] [Related]

  • 18. L-propionyl carnitine protects erythrocytes and low density lipoproteins against peroxidation.
    Bertelli A, Conte A, Ronca G.
    Drugs Exp Clin Res; 1994 Mar 25; 20(5):191-7. PubMed ID: 7875055
    [Abstract] [Full Text] [Related]

  • 19. Protective role of propionyl carnitine in vascular disorders experimentally induced by endothelin (ET-1) serotonin and K-carrageenin.
    Bertelli A, Giovannini L, Galmozzi G, Bertelli AA.
    Drugs Exp Clin Res; 1993 Mar 25; 19(1):7-11. PubMed ID: 8223141
    [Abstract] [Full Text] [Related]

  • 20. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy.
    Cavallini G, Modenini F, Vitali G, Koverech A.
    Urology; 2005 Nov 25; 66(5):1080-5. PubMed ID: 16286128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.